Despite fighting metastatic cancer, Rose feeling blessed

  “Truly blessed.” That response may seem unusual from someone who is battling a rare form of cancer, but that’s how Verna Rose feels. “My family’s support has been unbelievable,” said Rose, who more than two years ago was diagnosed with appendiceal carcinoma, a type of cancer that is so rare that it affects only about 10 people per 1 million. “My daughter (Ry AnnElise) gave up her job to take care of…

Continue Reading

Dalton headlining Distinguished Lecture Series

William S. (Bill) Dalton will be the featured speaker at the University of Illinois Cancer Center’s Distinguished Lecture Series on Thursday, Nov. 21, from 1:30 p.m. to 2:30 p.m. in the UIC College of Medicine Research Building’s Moss Auditorium (Room 1020), 909 S. Wolcott Ave. Dalton will present “Moving from Reactive to Proactive Medicine Through Data Science and Collective Impact.” Dalton, PhD, MD, is founder and executive chair of M2Gen, a national biotechnology…

Continue Reading

UI Cancer Center well represented at NCPF

Big data is being used in countless ways today: Dating, shopping, and regulating energy consumption, just to name a few ways. Now add cancer research. The National Cancer Policy Forum recently held a workshop for leading health care professionals to exchange ideas about how big data can be applied to address the social determinants in oncology and develop opportunities to improve health and reduce disparities. Robert Winn, MD, director of the University of…

Continue Reading

Newly activated UI Cancer Center Clinical Trials

The following study has recently been activated for patient enrollment by the University of Illinois Cancer Center Clinical Trials Office (CTO). Please click on the link to learn about the details regarding the study on clinicaltrials.gov. For more information or questions about the study, please email cancertrials@uic.edu or call 312-355-5112. A Phase II Study of Olaparib and Durvalumab in Men with Castration Sensitive Biochemically Recurrent Non-Metastatic Prostate Cancer Harboring Mutations in DNA Damage…

Continue Reading

Grant opportunity

The Mary Kay Foundation has a grant opportunity for cancer researchers. The University of Illinois Cancer Center will manage the limited competition and select one applicant for submission. Application deadline is Feb. 7, 2020. A link for the limited competition review process will be posted by Tuesday, Nov. 19. The Mary Kay Foundation is a non-profit public foundation focusing on funding research for innovative grants for translational research in ovarian, uterine, breast or…

Continue Reading

Kim’s work could uncover new therapeutics to treat some lung cancers

University of Illinois Cancer Center member Jiyeon Kim has been awarded a V Scholar Grant to conduct research on how fructose-mannose metabolism impacts tumor growth and aggressiveness in non-small cell lung cancer. Fructose – or fruit sugar – consumption increases the risk of colorectal cancer in mice, while mannose – a simple sugar related to glucose – does the opposite, slowing cancer growth in the animals, said Kim, PhD, assistant professor of biochemistry…

Continue Reading

Liu, Naylor join UI Cancer Center as members

Sandra Pinho and Takeshi Shimamura were recently introduced as new University of Illinois Cancer Center members. But they aren’t the only ones to join. Please welcome… New member to the University of Illinois Cancer Center: Ying Liu, PhD Associate Professor, Department of Chemical Engineering, Department of Biopharmaceutical Sciences  Ying Liu is an associate professor in the department of chemical engineering and adjunct professor in the department of bioengineering and department of biopharmaceutical sciences…

Continue Reading

Newly activated UI Cancer Center Clinical Trials

The following study has recently been activated for patient enrollment by the University of Illinois Cancer Center Clinical Trials Office (CTO). Please click on the link to learn about the details regarding the study on clinicaltrials.gov. For more information or questions about the study, please email cancertrials@uic.edu or call 312-355-5112. A Phase I Trial of Talimogene Laherparepvec for the Treatment of Periotoneal Surface Malignancies (TEMPO) Sponsor: Dan Blazer III, MD Principal Investigator: John…

Continue Reading

Doorenbos being invested as nursing collegiate professor

University of Illinois Cancer Center member Ardith Doorenbos, PhD, RN, FAAN, will be invested as Nursing Collegiate Professor in the UIC College of Nursing during a ceremony on Thursday, Nov. 7. Doorenbos, who serves as co-leader of the UI Cancer Center’s Cancer and Control Program, is internationally recognized for her contributions to the science of palliative care and pain and symptom management. In addition to her position as professor of biobehavioral health science,…

Continue Reading

Porcine study will help researchers better understand liver cancer

UI Health has received a National Cancer Institute grant to develop a new pig model to better understand hepatocellular carcinoma. University of Illinois Cancer Center members Ron Gaba and Kyle Schachtschneider serve as the grant’s co-principal investigators. Hepatocellular carcinoma (HCC) – the most common type of primary liver cancer – is the fifth most common cancer globally and the second most common cause of cancer death worldwide, said Gaba, MD, MS, associate professor…

Continue Reading